We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current OGEN market cap is 2.72M. The company's latest EPS is USD and P/E is N/A.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 87k | 0 | 17k | 13k | 8k |
Operating Income | -3.95M | -360k | -2.91M | -3.11M | -2.1M |
Net Income | -3.92M | -302k | -2.85M | -3.05M | -2.01M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 87k | 132k | 38k |
Operating Income | -15.88M | -26.64M | -15.77M | -14.42M | -20.91M |
Net Income | -15.57M | -26.43M | -15.71M | -14.29M | -20.66M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 15.04M | 14.76M | 12.13M | 8.46M | 7.9M |
Total Liabilities | 1.7M | 1.75M | 1.89M | 1.21M | 1.4M |
Total Equity | 13.34M | 13.01M | 10.24M | 7.26M | 6.5M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 19.75M | 18.68M | 28.23M | 14.76M | 4.97M |
Total Liabilities | 2.52M | 1.84M | 1.75M | 1.75M | 1.8M |
Total Equity | 17.23M | 16.85M | 26.49M | 13.01M | 3.17M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -12.8M | -15.23M | -2.11M | -4.69M | -6.19M |
Investing | -112k | -116k | N/A | N/A | 64k |
Financing | -407k | -495k | -160k | -268k | 464k |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -13.01M | -16.95M | -13.47M | -15.23M | -7.29M |
Investing | -25k | N/A | -44k | -116k | -936k |
Financing | 11.1M | 16.33M | 23.14M | -495k | 284k |
Market Cap | 2.72M |
Price to Earnings Ratio | N/A |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 2.57M |
Average Volume (1 week) | 31.63k |
Average Volume (1 Month) | 52.45k |
52 Week Change | -62.41% |
52 Week High | 7.74 |
52 Week Low | 1.00 |
Spread (Intraday) | 0.02 (1.89%) |
Company Name | Oragenics Inc |
Address |
101 east kennedy blvd tampa, florida 33602 |
Website | https:// |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions